Roche Diagnostics International AG
Roche Diagnostics International AG, a leading entity in the global healthcare sector, is headquartered in Switzerland (CH). Founded in 1896, Roche has established itself as a pioneer in diagnostics, focusing on innovative solutions that enhance patient care. The company operates extensively across Europe, North America, and Asia, providing cutting-edge diagnostic tools and services.
Roche's core offerings include molecular diagnostics, tissue diagnostics, and point-of-care testing, distinguished by their accuracy and reliability. The company is renowned for its commitment to research and development, which has led to significant advancements in personalised healthcare. With a strong market position, Roche Diagnostics is celebrated for its contributions to early disease detection and management, solidifying its reputation as a trusted leader in the diagnostics industry.
+20 vs industry average
Roche Diagnostics International AG’s score of 47 is higher than 69% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Roche Diagnostics International AG?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Medical Device Manufacturing has typical carbon intensity
Industry performance
The Medical Device Manufacturing industry has reduced its overall emissions by 18% since 2019
Reported emissions
No reported emissions data is available for Roche Diagnostics International AG yet.
Roche Diagnostics International AG's reported carbon emissions
Roche Diagnostics International AG, headquartered in Switzerland (CH), currently does not have specific carbon emissions data available for the most recent year. As a current subsidiary of Roche Holding AG, it inherits climate commitments and initiatives from its parent company.
Roche Holding AG has set ambitious climate targets, which are cascaded down to its subsidiaries, including Roche Diagnostics. The company is committed to reducing its carbon footprint and has engaged with the Science Based Targets initiative (SBTi) to align its emissions reduction strategies with global climate goals. However, specific reduction targets or achievements for Roche Diagnostics International AG have not been disclosed.
In the context of the broader industry, Roche Diagnostics is part of a movement towards sustainability, focusing on reducing greenhouse gas emissions across its operations. The company is actively involved in initiatives such as the Carbon Disclosure Project (CDP) and is committed to transitioning to renewable energy sources, although specific metrics or targets for these initiatives have not been provided.
Overall, while Roche Diagnostics International AG does not currently report specific emissions data, it is aligned with the climate commitments of its parent company, Roche Holding AG, and is part of a larger effort within the healthcare sector to address climate change.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Roche Diagnostics International AG’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Roche Diagnostics International AG yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisations
Roche Diagnostics International AG
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project